109 related articles for article (PubMed ID: 10099073)
1. Lack of cytochrome P450 1A2 interaction effect of ABT-761 on the pharmacokinetics of theophylline.
Wong SL; Cavanaugh JH; Qian J; Hansen R; Awni WM
Am J Ther; 1998 Sep; 5(5):303-6. PubMed ID: 10099073
[TBL] [Abstract][Full Text] [Related]
2. Effects of ABT-761, a novel 5-lipoxygenase inhibitor, on the pharmacokinetics of a single dose of ethinyl estradiol and levonorgestrel in healthy female volunteers.
Wong SL; O'Dea RF; Dube LM; Awni WM
J Clin Pharmacol; 1998 Jul; 38(7):642-8. PubMed ID: 9702850
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.
Lu P; Schrag ML; Slaughter DE; Raab CE; Shou M; Rodrigues AD
Drug Metab Dispos; 2003 Nov; 31(11):1352-60. PubMed ID: 14570767
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers.
Wong SL; Drajesk J; Chang M; Lanni C; Witt G; Hansen R; Awni WM
Clin Pharmacol Ther; 1998 Mar; 63(3):324-31. PubMed ID: 9542476
[TBL] [Abstract][Full Text] [Related]
5. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
[TBL] [Abstract][Full Text] [Related]
6. Effect of zileuton on theophylline pharmacokinetics.
Granneman GR; Braeckman RA; Locke CS; Cavanaugh JH; Dubé LM; Awni WM
Clin Pharmacokinet; 1995; 29 Suppl 2():77-83. PubMed ID: 8620674
[TBL] [Abstract][Full Text] [Related]
7. The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophylline.
Nix DE; Di Cicco RA; Miller AK; Boyle DA; Boike SC; Zariffa N; Jorkasky DK; Schentag JJ
J Clin Pharmacol; 1999 Aug; 39(8):855-65. PubMed ID: 10434239
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men.
Macias WL; Bergstrom RF; Cerimele BJ; Kassahun K; Tatum DE; Callaghan JT
Pharmacotherapy; 1998; 18(6):1237-48. PubMed ID: 9855322
[TBL] [Abstract][Full Text] [Related]
9. Effect of a newly developed ketolide antibiotic, telithromycin, on metabolism of theophylline and expression of cytochrome P450 in rats.
Nosaka H; Nadai M; Kato M; Yasui K; Yoshizumi H; Miyoshi M; Zhao YL; Baba K; Takagi K; Hasegawa T
Life Sci; 2006 May; 79(1):50-6. PubMed ID: 16423372
[TBL] [Abstract][Full Text] [Related]
10. Tegaserod coadministration does not alter the pharmacokinetics of theophylline in healthy subjects.
Zhou H; Khalilieh S; Svendsen K; Pommier F; Osborne S; Appel-Dingemanse S; Lasseter K; McLeod JF
J Clin Pharmacol; 2001 Sep; 41(9):987-93. PubMed ID: 11549104
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of aciclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats.
Nadai M; Kato M; Yasui K; Kimura M; Zhao YL; Ueyama J; Tsunekawa Y; Yoshizumi H; Hasegawa T
Biol Pharm Bull; 2007 Mar; 30(3):562-8. PubMed ID: 17329857
[TBL] [Abstract][Full Text] [Related]
12. No pharmacokinetic or pharmacodynamic interaction between theophylline and the leukotriene biosynthesis inhibitor BAY x 1005.
Groen H; Moesker HL; Leeuwenkamp OR; Sollie FA; Jonkman JH
J Clin Pharmacol; 1996 Jul; 36(7):639-46. PubMed ID: 8844447
[TBL] [Abstract][Full Text] [Related]
13. Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers.
Wong SL; Drajesk J; Chang MS; Witt G; Awni WM
Biopharm Drug Dispos; 1998 Apr; 19(3):159-62. PubMed ID: 9569998
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma.
Wong SL; Kearns GL; Kemp JP; Drajesk J; Chang M; Locke CS; Dube LM; Awni WM
Eur J Clin Pharmacol; 1998; 54(9-10):715-9. PubMed ID: 9923573
[TBL] [Abstract][Full Text] [Related]
15. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.
Van Schoor J; Joos GF; Kips JC; Drajesk JF; Carpentier PJ; Pauwels RA
Am J Respir Crit Care Med; 1997 Mar; 155(3):875-80. PubMed ID: 9117020
[TBL] [Abstract][Full Text] [Related]
16. ABT-761 (Abbott).
Reid JJ
Curr Opin Investig Drugs; 2001 Jan; 2(1):68-71. PubMed ID: 11527015
[TBL] [Abstract][Full Text] [Related]
17. Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers.
Peng WX; Li HD; Zhou HH
Eur J Clin Pharmacol; 2003 Jul; 59(3):237-41. PubMed ID: 12756512
[TBL] [Abstract][Full Text] [Related]
18. Effect of alosetron on theophylline pharmacokinetics.
Koch KM; Ricci BM; Hedayetullah NS; Jewell D; Kersey KE
Br J Clin Pharmacol; 2001 Nov; 52(5):596-600. PubMed ID: 11736869
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats.
Zhang YH; Zhang YJ; Guo YL; Li WJ; Yu C
J Pharm Pharmacol; 2013 Jan; 65(1):149-55. PubMed ID: 23215698
[TBL] [Abstract][Full Text] [Related]
20. Study investigating pharmacokinetic interaction between theophylline and roflumilast in healthy adults.
Böhmer G; Gleiter CH; Hünnemeyer A; Lahu G; Bethke TD
Int J Clin Pharmacol Ther; 2011 Jul; 49(7):451-60. PubMed ID: 21726496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
